Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Merck Millipore Introduces Amicon® Pro Purification System for Protein Purification

Published: Tuesday, April 09, 2013
Last Updated: Tuesday, April 09, 2013
Bookmark and Share
Combines the bind, wash, elute, buffer exchange and concentration steps into one device.

Merck Millipore has introduced Amicon® Pro Purification System for Protein Purification. This centrifugal device streamlines the affinity purification workflow and minimizes protein loss.

Users experience consistent, accurate sample preparation, resulting in more reliable recovery, uncompromised purity and easier data generation.

The Amicon® Pro purification system combines the bind, wash, elute, buffer exchange and concentration steps into one device, eliminating risky sample transfers and reducing hands-on time.

The device integrates affinity-based spin column purification with downstream sample concentration and buffer exchange.

Featuring a large reservoir that accommodates a range of sample volumes, the Amicon® Pro system reduces the need for multiple washing and elution steps.

"Traditional protein purification is a long process with many steps, dilutions and multiple tubes, often resulting in protein degradation and loss," notes John Sweeney, Head of the Bioscience business unit, Merck Millipore.

Sweeney continued, "The Amicon® Pro affinity purification system is a game-changing improvement in general affinity purification and also transforms applications such as depletion of abundant proteins, protein enrichment and clean-up of antibody labeling reactions."

In addition to fast and efficient affinity purification, the Amicon® device supports single-spin diafiltration and depletion with concentration in a single step.

The Amicon® Pro purification system also provides the ideal processing tool for small-batch antibody labeling.

Antibody labeling and high-yield purification can be completed in as little as one hour.

Antibody cleanup routinely involves the removal of BSA/carrier, labeling, removal of unbound label, dialysis, and final concentration.

Using standard dialysis, the procedure can take up to three days to complete. With the all-in-one format of the Amicon® Pro device, loss due to sample transfers is eliminated and recovery can be significantly improved.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Agreement with Precision Biologics
Merck Millipore services include design and development of cost-effective process to deliver high yield and productivity.
Thursday, February 05, 2015
Merck Millipore Partners with Gyros
Partnership to develop, manufacture and commercialize kits on the Gyrolab™ immunoassay platform.
Tuesday, July 16, 2013
Merck Millipore Announces Partnership with NIH Consortium
Adds more than 140 peer-validated neuroscience-specific monoclonal antibodies to portfolio.
Tuesday, October 16, 2012
Scientific News
Flu Vaccine May Reduce Death Risk of Type 2 Diabetes
New research suggests that a new flu vaccine may reduce probability of type 2 diabetes patients being hospitalised with stroke and heart failure.
Gut Bacteria Older than Human Species
Some bacteria have lived in the human gut since before we were human, suggesting evolution could have a larger role inhuman bacterial makeup.
Evidence of Mosquito Transmitting Zika
A direct link between the Yellow fever mosquito and Zika transmission has been found following investigation into selective mosquito control.
Antibody-Based Drug for Multiple Sclerosis
New antibody-based drug paves the way for new strategies for controlling and treating multiple sclerosis.
Three-Drug Combinations Counter Antibiotic Resistance
Research shows that combinations of three different antibiotics can treat resistant bacteria, even if they are ineffective independently.
Mapping Zika’s Routes to Developing Fetus
UC researchers show how Zika virus travels from a pregnant woman to her fetus, and also identified a drug that could stop it.
Treating HIV with Cancer-Fighting Gene Shows Promise
A type of gene immunotherapy that has shown promising results against cancer could also be used against HIV.
Protein Teams Activate T-Cells
Caltech researchers have discovered T-cell genetic switching is controlled by four proteins acting in a multi-tiered fashion.
'Antigen-Presenting Cell' Defends Against Cancer
Through advanced imaging, researchers have identified cells that encourages increases in immune system cancer defences.
Zika Epidemic Likely to End Within Three Years
A team of scientists has predicted that the current Zika epidemic is likely to end within three years because there will be too few people left to infect.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!